A proposal for a drug product Manufacturing Classification System (MCS) for oral solid dosage forms

Abstract This paper proposes the development of a drug product Manufacturing Classification System (MCS) based on processing route. It summarizes conclusions from a dedicated APS conference and subsequent discussion within APS focus groups and the MCS working party. The MCS is intended as a tool for pharmaceutical scientists to rank the feasibility of different processing routes for the manufacture of oral solid dosage forms, based on selected properties of the API and the needs of the formulation. It has many applications in pharmaceutical development, in particular, it will provide a common understanding of risk by defining what the “right particles” are, enable the selection of the best process, and aid subsequent transfer to manufacturing. The ultimate aim is one of prediction of product developability and processability based upon previous experience. This paper is intended to stimulate contribution from a broad range of stakeholders to develop the MCS concept further and apply it to practice. In particular, opinions are sought on what API properties are important when selecting or modifying materials to enable an efficient and robust pharmaceutical manufacturing process. Feedback can be given by replying to our dedicated e-mail address (mcs@apsgb.org); completing the survey on our LinkedIn site; or by attending one of our planned conference roundtable sessions.

[1]  W J Thiel,et al.  Fluidized bed granulation of an ordered powder mixture , 1982, The Journal of pharmacy and pharmacology.

[2]  Ming Huang,et al.  Solubilization of entecavir by povidone to overcome content uniformity challenges for low-dose tablet formulations , 2013, Pharmaceutical development and technology.

[3]  K R Morris,et al.  Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. , 2001, Advanced drug delivery reviews.

[4]  Hans Leuenberger,et al.  The application of percolation theory in powder technology , 1999 .

[5]  Qi Gao,et al.  Imaging dehydration kinetics of a channel hydrate form of the HIV-1 attachment inhibitor prodrug BMS-663068. , 2013, Journal of pharmaceutical sciences.

[6]  James I. Wells,et al.  Pharmaceutical preformulation : the physicochemical properties of drug substances , 1988 .

[7]  V. Caron,et al.  Transformation of pharmaceutical compounds upon milling and comilling: the role of T(g). , 2007, Journal of pharmaceutical sciences.

[8]  Carl A Anderson,et al.  Demonstration of a shear-based solid-state phase transformation in a small molecular organic system: chlorpropamide. , 2007, Journal of pharmaceutical sciences.

[9]  Dongsheng Bu,et al.  A control strategy for bioavailability enhancement by size reduction: Effect of micronization conditions on the bulk, surface and blending characteristics of an active pharmaceutical ingredient , 2014 .

[10]  A. Serajuddin,et al.  Application of melt granulation technology to enhance tabletting properties of poorly compactible high-dose drugs. , 2011, Journal of pharmaceutical sciences.

[11]  Koichi Wada,et al.  Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. , 2011, International journal of pharmaceutics.

[12]  R. J. Roberts,et al.  The compaction of pharmaceutical and other model materials ― a pragmatic approach , 1987 .

[13]  A. Stepan,et al.  Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. , 2011, Chemical research in toxicology.

[14]  Kazutaka Kitagawa,et al.  Effect of Particle Shape on the Compaction and Flow Properties of Powders , 1989 .

[15]  J. T. Carstensen,et al.  Relation between particle size and repose angles of powders , 1976 .

[16]  G. Amidon,et al.  Particle size limits to meet USP content uniformity criteria for tablets and capsules. , 2006, Journal of pharmaceutical sciences.

[17]  Weiqin Tong,et al.  Application of melt granulation technology using twin-screw extruder in development of high-dose modified-release tablet formulation. , 2011, Journal of pharmaceutical sciences.

[18]  Ajit S. Narang,et al.  Molecular Basis of Crystal Morphology-Dependent Adhesion Behavior of Mefenamic Acid During Tableting , 2013, Pharmaceutical Research.

[19]  Hassan Benameur,et al.  Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration. , 2008, Advanced drug delivery reviews.

[20]  G. Levy,et al.  United States Pharmacopeia and National Formulary standards, Food and Drug Administration regulations, and the quality of drugs. , 1961, New York state journal of medicine.

[21]  Feng Zhang,et al.  Assessment of granulation technologies for an API with poor physical properties , 2013, Drug development and industrial pharmacy.

[22]  Bruno C. Hancock,et al.  The relative densities of pharmaceutical powders, blends, dry granulations, and immediate-release tablets , 2003 .

[23]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[24]  David Littlejohn,et al.  Effects of particle size and cohesive properties on mixing studied by non-contact NIR. , 2008, International journal of pharmaceutics.

[25]  Jm Newton,et al.  Powder flowability as an indication of capsule filling performance , 1990 .

[26]  Feng Qian,et al.  Formulation and process design for a solid dosage form containing a spray-dried amorphous dispersion of ibipinabant , 2013, Pharmaceutical development and technology.

[27]  R. Daniels,et al.  Pharmaceutical Preformulation – The Physicochemical Properties of Drug Substances ‐ von James I. Wells, 227 S., 47 Abb., 99 Tab., Preis: £ 35.00, Ellis Horwood Limited, Chichester, England 1988 , 1989 .

[28]  Derek Geldart,et al.  The use of bulk density measurements as flowability indicators , 1999 .

[29]  Praful Agrawala,et al.  Pharmaceutical Preformulation: The Physicochemical Properties of Drug Substances , 1990 .

[30]  S. Yalkowsky,et al.  Particle Size and Content Uniformity , 1990, Pharmaceutical Research.

[31]  Joseph P. Neilly,et al.  A material sparing method for quantitatively measuring tablet sticking , 2011 .

[32]  Douglas Mccormick,et al.  Evolutions in direct compression , 2005 .

[33]  Siegfried Wartewig,et al.  Potential of carrageenans to protect drugs from polymorphic transformation. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[34]  Matthew G. Heasley,et al.  Determination of the tensile strength of elongated tablets , 2013 .

[35]  Jukka Rantanen,et al.  Excipient selection can significantly affect solid-state phase transformation in formulation during wet granulation , 2005, AAPS PharmSciTech.

[36]  Ronald G Iacocca,et al.  Particle engineering: a strategy for establishing drug substance physical property specifications during small molecule development. , 2010, Journal of pharmaceutical sciences.

[37]  Khaled Bouri,et al.  Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012. , 2014, JAMA.

[38]  Matthew Roberts,et al.  Effects of surface roughness and chrome plating of punch tips on the sticking tendencies of model ibuprofen formulations , 2003, The Journal of pharmacy and pharmacology.

[39]  San Kiang,et al.  Crystallization Process Development of an Active Pharmaceutical Ingredient and Particle Engineering via the Use of Ultrasonics and Temperature Cycling , 2003 .

[40]  Jianhong Jennifer Wang.  Modeling of adhesion in tablet compression , 2002 .

[41]  Robert Erck,et al.  Modeling of adhesion in tablet compression--I. Atomic force microscopy and molecular simulation. , 2003, Journal of pharmaceutical sciences.

[42]  Divyakant Desai,et al.  An active film-coating approach to enhance chemical stability of a potent drug molecule , 2012, Pharmaceutical development and technology.

[43]  Jm Newton,et al.  Influence of particle size on the adhesion behaviour of powders, after application of an initial press-on force , 1992 .